Jupiter Neurosciences files Form D for $774,787 private offering

Jupiter Neurosciences, Inc., based in Palm Beach Gardens, Florida, filed a Form D notice with the Securities and Exchange Commission dated September 4, 2026, disclosing a private securities offering. The total offering amount was listed as $774,787, with the same figure reported as the total amount sold and $0 remaining to be sold.¹

The filing was marked as a new notice, with a date of first sale of August 20, 2026.¹ The security type offered was equity.¹ The company reported a total of one investor who had already invested in the offering.¹

The offering was conducted under the Rule 506(b) exemption.¹ The company indicated the offering was not made in connection with a business combination transaction such as a merger or acquisition.¹ No sales commissions or finders' fees were reported, both listed at $0.¹ The filing also reported $0 in proceeds directed to payments for executive officers, directors, or promoters.¹

The issuer's previous name was Jupiter Orphan Therapeutics, Inc., before changing to Jupiter Neurosciences, Inc.¹ The company is incorporated in Delaware and was formed over five years ago.¹

The filing lists Christer Rosen as Chief Executive Officer, Alison Silva as Chief Operating Officer, Saleem Elmasri as Chief Financial Officer, Marshall Hayward as Chief Scientific Officer, and Alexander Rosen as Chief Administrative Officer¹, among other named executive officers and directors. The notice was signed by Christer Rosen as Chief Executive Officer on September 4, 2026.¹